{"id":"W4410051475","doi":"10.1038/s41391-025-00975-8","title":"Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Hospital Foundation","funders":"Astellas Pharma Global Development; Astellas Pharma Europe","keywords":"Medicine; Enzalutamide; Prostate cancer; Androgen deprivation therapy; Zoledronic acid; Oncology; Internal medicine; Randomized controlled trial; Hormone therapy; Androgen; Urology; Cancer; Hormone; Androgen receptor; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001578938,0.002195618,0.003505803,0.0005174478,0.0004043863,0.001490548,0.001317624,0.001595491,0.007514516],"category_scores_gemma":[0.001528492,0.0007199346,0.002852331,0.0005775699,0.001488162,0.001257101,0.000637104,0.003866977,0.001213961],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001187362,"about_ca_system_score_gemma":0.001342832,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002907345,"about_ca_topic_score_gemma":0.006623335,"domain_scores_codex":[0.9993942,0.0002985854,0.00002922627,0.000116306,0.0000495914,0.000112164],"domain_scores_gemma":[0.9993888,0.000157445,0.000128396,0.00005718916,0.00003570673,0.0002323752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9779406,0.002029188,0.0005048884,0.0005190457,0.001556605,0.0000231204,0.00004224585,0.0007239842,0.00135918,0.0001830315,0.001145504,0.0139726],"study_design_scores_gemma":[0.9663678,0.02945559,0.001750021,0.00003353858,0.0007751294,0.00003862104,0.00002445995,0.0003120639,0.0002178649,0.0002215582,0.0007890757,0.00001428757],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9738038,0.01347088,0.0009237491,0.001822415,0.001263411,0.001893446,0.002352638,0.0002497303,0.004219991],"genre_scores_gemma":[0.9791351,0.006265227,0.00150245,0.001922385,0.0005499328,0.001691478,0.002963971,0.00005938498,0.005910159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007514516,"threshold_uncertainty_score":0.02513856,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02157286311021882,"score_gpt":0.3525904308068917,"score_spread":0.3310175676966728,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}